Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder Medical Dialogues Bureau9 March 2020 6:56 AMIRVINE -Urovant Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application...